Depression is one of the most frequent psychiatric symptoms observed in people during the development of Alzheimer’s disease (AD). We hypothesized that genetic factors conferring risk of depression might affect AD development. In this study, we screened 31 genes, which were located in 19 risk loci for major depressive disorder (MDD) identified by two recent large genome-wide association studies (GWAS), in AD patients at the genomic and transcriptomic levels. Association analysis of common variants was performed by using summary statistics of the International Genomics of Alzheimer’s Project (IGAP), and association analysis of rare variants was conducted by sequencing the entire coding region of the 31 MDD risk genes in 107 Han Chinese patients with early-onset and/or familial AD. We also quantified the mRNA expression alterations of these MDD risk genes in brain tissues of AD patients and AD mouse models, followed by protein-protein interaction network prediction to show their potential effects in AD pathways. We found that common and rare variants of L3MBTL2 were significantly associated with AD. mRNA expression levels of 18 MDD risk genes, in particular SORCS3 and OAT, were differentially expressed in AD brain tissues. 13 MDD risk genes were predicted to physically interact with core AD genes. The involvement of HACE1, NEGR1, and SLC6A15 in AD was supported by convergent lines of evidence. Taken together, our results showed that MDD risk genes might play an active role in AD pathology and supported the notion that depression might be the “common cold” of psychiatry.
Alzheimer’s Association (2016) 2016 Alzheimer’s disease facts and figures. Alzheimers Dement12, 459–509.
2.
Alzheimer’s Association (2015) 2015 Alzheimer’s disease facts and figures. Alzheimers Dement11, 332–384.
3.
LyketsosCG, LopezO, JonesB, FitzpatrickAL, BreitnerJ, DeKoskyS (2002) Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health study. JAMA288, 1475–1483.
4.
LeeHB, LyketsosCG (2003) Depression in Alzheimer’s disease: Heterogeneity and related issues. Biol Psychiatry54, 353–362.
5.
GurejeO, KolaL, AfolabiE (2007) Epidemiology of major depressive disorder in elderly Nigerians in the Ibadan Study of Ageing: A community-based survey. Lancet370, 957–964.
6.
KesslerRC, BerglundP, DemlerO, JinR, KoretzD, MerikangasKR, RushAJ, WaltersEE, WangPS (2003) The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA289, 3095–3105.
7.
TaraganoFE, AllegriRF, KrupitzkiH, SarasolaDR, SerranoCM, LonL, LyketsosCG (2009) Mild behavioral impairment and risk of dementia: A prospective cohort study of 358 patients. J Clin Psychiatry70, 584–592.
8.
SpiraAP, RebokGW, StoneKL, KramerJH, YaffeK (2012) Depressive symptoms in oldest-old women: Risk of mild cognitive impairment and dementia. Am J Geriatr Psychiatry20, 1006–1015.
SpeckCE, KukullWA, BrennerDE, BowenJD, McCormickWC, TeriL, PfanschmidtML, ThompsonJD, LarsonEB (1995) History of depression as a risk factor for Alzheimer’s disease. Epidemiology6, 366–369.
11.
WilsonRS, BarnesLL, Mendes de LeonCF, AggarwalNT, SchneiderJS, BachJ, PilatJ, BeckettLA, ArnoldSE, EvansDA, BennettDA (2002) Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology59, 364–370.
12.
GatzJL, TyasSL, St JohnP, MontgomeryP (2005) Do depressive symptoms predict Alzheimer’s disease and dementia?. J Gerontol A Biol Sci Med Sci60, 744–747.
13.
MirzaSS, WoltersFJ, SwansonSA, KoudstaalPJ, HofmanA, TiemeierH, IkramMA (2016) 10-year trajectories of depressive symptoms and risk of dementia: A population-based study. Lancet Psychiatry3, 628–635.
14.
SullivanPF, NealeMC, KendlerKS (2000) Genetic epidemiology of major depression: Review and meta-analysis. Am J Psychiatry157, 1552–1562.
15.
GatzM, ReynoldsCA, FratiglioniL, JohanssonB, MortimerJA, BergS, FiskeA, PedersenNL (2006) Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry63, 168–174.
16.
ZhangC, ZhangDF, WuZG, PengDH, ChenJ, NiJ, TangW, XuL, YaoYG, FangYR (2016) Complement factor H and susceptibility to major depressive disorder in Han Chinese. Br J Psychiatry208, 446–452.
HydeCL, NagleMW, TianC, ChenX, PacigaSA, WendlandJR, TungJY, HindsDA, PerlisRH, WinslowAR (2016) Identification of 15 genetic loci associated with risk of major depression in individuals of European descent. Nat Genet48, 1031–1036.
MugliaP, TozziF, GalweyNW, FrancksC, UpmanyuR, KongXQ, AntoniadesA, DomeniciE, PerryJ, RothenS, VandeleurCL, MooserV, WaeberG, VollenweiderP, PreisigM, LucaeS, Muller-MyhsokB, HolsboerF, MiddletonLT, RosesAD (2010) Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts. Mol Psychiatry15, 589–601.
22.
ShiJ, PotashJB, KnowlesJA, WeissmanMM, CoryellW, ScheftnerWA, LawsonWB, DePauloJRJr, GejmanPV, SandersAR, JohnsonJK, AdamsP, ChaudhuryS, JancicD, EvgrafovO, ZvinyatskovskiyA, ErtmanN, GladisM, NeimanasK, GoodellM, HaleN, NeyN, VermaR, MirelD, HolmansP, LevinsonDF (2011) Genome-wide association study of recurrent early-onset major depressive disorder. Mol Psychiatry16, 193–201.
23.
CONVERGE consortium (2015) Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature523, 588–591.
24.
LiuJZ, McRaeAF, NyholtDR, MedlandSE, WrayNR, BrownKM, HaywardNK, MontgomeryGW, VisscherPM, MartinNG, MacgregorS (2010) A versatile gene-based test for genome-wide association studies. Am J Hum Genet87, 139–145.
25.
MishraA, MacgregorS (2015) VEGAS2: Software for more flexible gene-based testing. Twin Res Hum Genet18, 86–91.
26.
BolgerAM, LohseM, UsadelB (2014) Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics30, 2114–2120.
27.
LiH, DurbinR (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics25, 1754–1760.
28.
Van der AuweraGA, CarneiroMO, HartlC, PoplinR, Del AngelG, Levy-MoonshineA, JordanT, ShakirK, RoazenD, ThibaultJ, BanksE, GarimellaKV, AltshulerD, GabrielS, DePristoMA (2013) From FastQ data to high confidence variant calls: The Genome Analysis Toolkit best practices pipeline.11 10. Curr Protoc Bioinformatics43, 11–33.
29.
WangK, LiM, HakonarsonH (2010) ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res38, e164.
30.
WangD, FanY, MalhiM, BiR, WuY, XuM, YuXF, LongH, LiYY, ZhangDF, YaoYG (2018) Missense variants in HIF1A and LACC1 contribute to leprosy risk in Han Chinese. Am J Hum Genet102, 794–805.
31.
The 1000 Genomes Project Consortium,
AutonA, BrooksLD, DurbinRM, GarrisonEP, KangHM, KorbelJO, MarchiniJL, McCarthyS, McVeanGA, AbecasisGR (2015) A global reference for human genetic variation. Nature526, 68–74.
XuM, ZhangDF, LuoR, WuY, ZhouH, KongLL, BiR, YaoYG (2018) A systematic integrated analysis of brain expression profiles reveals YAP1 and other prioritized hub genes as important upstream regulators in Alzheimer’s disease. Alzheimers Dement14, 215–229.
34.
MatarinM, SalihDA, YasvoinaM, CummingsDM, GuelfiS, LiuW, Nahaboo SolimMA, MoensTG, PaubleteRM, AliSS, PeronaM, DesaiR, SmithKJ, LatchamJ, FulleyloveM, RichardsonJC, HardyJ, EdwardsFA (2015) A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. Cell Rep10, 633–644.
NiculescuAB3rd, SegalDS, KuczenskiR, BarrettT, HaugerRL, KelsoeJR (2000) Identifying a series of candidate genes for mania and psychosis: A convergent functional genomics approach. Physiol Genomics4, 83–91.
37.
NiculescuAB, Le-NiculescuH (2010) Convergent Functional Genomics: What we have learned and can learn about genes, pathways, and mechanisms. Neuropsychopharmacology35, 355–356.
38.
HuangKL, MarcoraE, PimenovaAA, Di NarzoAF, KapoorM, JinSC, HarariO, BertelsenS, FairfaxBP, CzajkowskiJ, ChourakiV, Grenier-BoleyB, BellenguezC, DemingY, McKenzieA, RajT, RentonAE, BuddeJ, SmithA, FitzpatrickA, BisJC, DeStefanoA, AdamsHHH, IkramMA, van der LeeS, Del-AguilaJL, FernandezMV, IbanezL, SimsR, Escott-PriceV, MayeuxR, HainesJL, FarrerLA, Pericak-VanceMA, LambertJC, van DuijnC, LaunerL, SeshadriS, WilliamsJ, AmouyelP, SchellenbergGD, ZhangB, BoreckiI, KauweJSK, CruchagaC, HaoK, GoateAM (2017) A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer’s disease. Nat Neurosci20, 1052–1061.
39.
KaupAR, ByersAL, FalveyC, SimonsickEM, SatterfieldS, AyonayonHN, SmagulaSF, RubinSM, YaffeK (2016) Trajectories of depressive symptoms in older adults and risk of dementia. JAMA Psychiatry73, 525–531.
40.
SaczynskiJS, BeiserA, SeshadriS, AuerbachS, WolfPA, AuR (2010) Depressive symptoms and risk of dementia: The Framingham Heart Study. Neurology75, 35–41.
41.
GibsonJ, RussTC, AdamsMJ, ClarkeTK, HowardDM, HallLS, Fernandez-PujalsAM, WigmoreEM, HaywardC, DaviesG, MurrayAD, SmithBH, PorteousDJ, DearyIJ, McIntoshAM (2017) Assessing the presence of shared genetic architecture between Alzheimer’s disease and major depressive disorder using genome-wide association data.e. Transl Psychiatry7, e1094.
42.
BarbosaAC, KimMS, ErtuncM, AdachiM, NelsonED, McAnallyJ, RichardsonJA, KavalaliET, MonteggiaLM, Bassel-DubyR, OlsonEN (2008) MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function. Proc Natl Acad Sci U S A105, 9391–9396.
43.
LoMT, HindsDA, TungJY, FranzC, FanCC, WangY, SmelandOB, SchorkA, HollandD, KauppiK, SanyalN, Escott-PriceV, SmithDJ, O’DonovanM, StefanssonH, BjornsdottirG, ThorgeirssonTE, StefanssonK, McEvoyLK, DaleAM, AndreassenOA, ChenCH (2017) Genome-wide analyses for personality traits identify six genomic loci and show correlations with psychiatric disorders. Nat Genet49, 152–156.
44.
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) Biological insights from 108 schizophrenia-associated genetic loci. Nature511, 421–427.
45.
SpiechowiczM, BernsteinHG, DobrowolnyH, LesniakW, MawrinC, BogertsB, KuznickiJ, FilipekA (2006) Density of Sgt1-immunopositive neurons is decreased in the cerebral cortex of Alzheimer’s disease brain. Neurochem Int49, 487–493.
BreiderhoffT, ChristiansenGB, PallesenLT, VaegterC, NykjaerA, HolmMM, GlerupS, WillnowTE (2013) Sortilin-related receptor SORCS3 is a postsynaptic modulator of synaptic depression and fear extinction.e. PLoS One8, e75006.
48.
ReitzC, TokuhiroS, ClarkLN, ConradC, VonsattelJP, HazratiLN, PalotasA, LantiguaR, MedranoM, IZJ-V, VardarajanB, SimkinI, HainesJL, Pericak-VanceMA, FarrerLA, LeeJH, RogaevaE, George-HyslopPS, MayeuxR (2011) SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer’s disease risk. Ann Neurol69, 47–64.
49.
PedersenCB, MorsO, BertelsenA, WaltoftBL, AgerboE, McGrathJJ, MortensenPB, EatonWW (2014) A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders. JAMA Psychiatry71, 573–581.
50.
LiG, WangLY, ShoferJB, ThompsonML, PeskindER, McCormickW, BowenJD, CranePK, LarsonEB (2011) Temporal relationship between depression and dementia: Findings from a large community-based 15-year follow-up study. Arch Gen Psychiatry68, 970–977.
51.
MauricioM, O’HaraR, YesavageJA, FriedmanL, KraemerHC, Van De WaterM, MurphyGMJr (2000) A longitudinal study of apolipoprotein-E genotype and depressive symptoms in community-dwelling older adults. Am J Geriatr Psychiatry8, 196–200.
